D. Western Therapeutics Institute (TSE:4576) EV-to-Revenue : 10.23 (As of Jun. 02, 2025)

D. Western Therapeutics Institute EV-to-Revenue Chart

D. Western Therapeutics Institute Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-Revenue		Get a 7-Day Free Trial					18.58	11.52	15.04	8.28	17.05

D. Western Therapeutics Institute Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial															10.17	8.28	8.68	6.09	17.05

Competitive Comparison of D. Western Therapeutics Institute's EV-to-Revenue

For the Biotechnology subindustry, D. Western Therapeutics Institute's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

D. Western Therapeutics Institute's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where D. Western Therapeutics Institute's EV-to-Revenue falls into.

D. Western Therapeutics Institute EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

D. Western Therapeutics Institute's EV-to-Revenue for today is calculated as:

D. Western Therapeutics Institute's current Enterprise Value is 円4,750.2 Mil.
D. Western Therapeutics Institute's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円464.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute  (TSE:4576) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

D. Western Therapeutics Institute's PS Ratiofor today is calculated as:

D. Western Therapeutics Institute's share price for today is 円122.00.
D. Western Therapeutics Institute's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14.33.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of D. Western Therapeutics Institute's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

D. Western Therapeutics Institute Business Description